Cited by 896Advanced Glycation End Products researchCell Adhesion Molecules ResearchNitric Oxide and Endothelin Effects

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes.

Open access

Schmidt, A M, Hori, O, Chen, J X, Li, J F, Crandall, J, Zhang, J, Cao, R, Yan, S D, Brett, J, Stern, D·1995·Journal of Clinical Investigation

DOI 10.1172/jci118175PMC PMC185762

Open this paper in CoChat — free account Open PDF

Abstract

Vascular cell adhesion molecule-1 (VCAM-1), an inducible cell-cell recognition protein on the endothelial cell surface (EC), has been associated with early stages of atherosclerosis. In view of the accelerated vascular disease observed in patients with diabetes, and the enhanced expression of VCAM-1 in diabetic rabbits, we examined whether irreversible advanced glycation endproducts (AGEs), could mediate VCAM-1 expression by interacting with their endothelial cell receptor (receptor for AGE, RAGE). Exposure of cultured human ECs to AGEs induced expression of VCAM-1, increased adhesivity of the monolayer for Molt-4 cells, and was associated with increased levels of VCAM-1 transcripts. The inhibitory effect of anti-RAGE IgG, a truncated form of the receptor (soluble RAGE) or N-acetylcysteine on VCAM-1 expression indicated that AGE-RAGE-induced oxidant stress was central to VCAM-1 induction. Electrophoretic mobility shift assays on nuclear extracts from AGE-treated ECs showed induction of specific DNA binding activity for NF-kB in the VCAM-1 promoter, which was blocked by anti-RAGE IgG or N-acetylcysteine. Soluble VCAM-1 antigen was elevated in human diabetic plasma. These data are consistent with the hypothesis that AGE-RAGE interaction induces expression of VCAM-1 which can prime diabetic vasculature for enhanced interaction with circulating monocytes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1172/jci118175

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
Chirgwin, J. M., Przybyla, A., MacDonald, R. J., & Rutter, W. J. (1979) · Biochemistry · doi:10.1021/bi00591a005 · Cited by 21,460
Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria.
Jaffe, E. A., Nachman, R., Becker, C. G., & Minick, C. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107470 · Cited by 7,146
Rapid detection of octamer binding proteins with ‘mini extracts’, prepared from a small number of cells
Schreiber, E. H., Matthias, P., Müller, M. M., & Schaffner, W. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.15.6419 · Cited by 4,179
Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF‐kappa B transcription factor and HIV‐1.
Schreck, R., RIEBER, P., & Baeuerle, P. A. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07761.x · Cited by 3,793
Role of Oxidative Stress in Development of Complications in Diabetes
Baynes, J. (1991) · Diabetes · doi:10.2337/diab.40.4.405 · Cited by 3,791
Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic Complications
Flier, J. S., Underhill, L. H., Brownlee, M., Cerami, A., & Vlassara, H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805193182007 · Cited by 2,512
Endothelial Expression of a Mononuclear Leukocyte Adhesion Molecule During Atherogenesis
Cybulsky, M. I., & Gimbrone, M. A. (1991) · Science · doi:10.1126/science.1990440 · Cited by 1,710
Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins.
Neeper, M. P., Schmidt, A. M., Brett, J., Yan, S. D., Wang, F., Pan, Y., Elliston, K. O., Stern, D., & SHAW, A. R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42138-2 · Cited by 1,545
Self-citation
Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins
Yan, S. D., Schmidt, A. M., Anderson, G. M., Zhang, J., Brett, J., Zou, Y., Pinsky, D. J., & Stern, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36966-1 · Cited by 1,305
Self-citation
Cytokines and endothelial cell biology
Pober, J. S., & Cotran, R. S. (1990) · Physiological Reviews · doi:10.1152/physrev.1990.70.2.427 · Cited by 1,251

Flagged first, then by citations

Show all 43 references

Sorted by citations

Items 201–300 of 893

Macrophages and Diabetic Nephropathy
Tesch, G. H. (2010) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2010.03.007 · Cited by 136
Polycystic Ovary Syndrome: The influence of environmental and genetic factors
Diamanti‐Kandarakis, E., Piperi, C., Argyrakopoulou, G., Spina, J., Papanastasiou, L., Bergiele, A. T., & Panidis, D. (2006) · HORMONES · doi:10.14310/horm.2002.11165 · Cited by 136
Endothelial dysfunctions: common denominators in vascular disease
Caterina, R. D. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200002000-00003 · Cited by 131
Tempering the wrath of RAGE: An emerging therapeutic strategy against diabetic complications, neurodegeneration, and inflammation
Yan, S. F., Yan, S. D., Ramasamy, R., & Schmidt, A. M. (2009) · Annals of Medicine · doi:10.1080/07853890902806576 · Cited by 135
Self-citation
Early- and advanced non-enzymatic glycation in diabetic vascular complications: the search for therapeutics
Schalkwijk, C. G., & Miyata, T. (2010) · Amino Acids · doi:10.1007/s00726-010-0779-9 · Cited by 135
New indices of ischemic heart disease and aging: studies on the serum levels of soluble intercellular adhesion molecule-1 (ICAM-1) and soluble vascular cell adhesion molecule-1 (VCAM-1) in patients with hypercholesterolemia and ischemic heart disease
Morisaki, N. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)06083-8 · Cited by 132
Toxic action of advanced glycation end products on cultured retinal capillary pericytes and endothelial cells: relevance to diabetic retinopathy
Chibber, R., Molinatti, P. A., Rosatto, N., Lambourne, B., & KOHNER, E. M. (1997) · Diabetologia · doi:10.1007/s001250050657 · Cited by 133
Urea-induced ROS cause endothelial dysfunction in chronic renal failure
D’Apolito, M., Du, X., Pisanelli, D., Pettoello‐Mantovani, M., Campanozzi, A., Giacco, F., Maffione, A. B., Colia, A. L., Brownlee, M., & Giardino, I. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.01.034 · Cited by 131
Blockade of Late Stages of Autoimmune Diabetes by Inhibition of the Receptor for Advanced Glycation End Products
Chen, Y., Yan, S. S., Colgan, J. D., Zhang, H.-P., Luban, J., Schmidt, A. M., Stern, D. M., & Herold, K. C. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.1399 · Cited by 130
Self-citation
The Clinical Relevance of Advanced Glycation Endproducts (AGE) and Recent Developments in Pharmaceutics to Reduce AGE Accumulation
Smit, A. J., & Lutgers, H. L. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043364342 · Cited by 133
The molecular link between oxidative stress, insulin resistance, and type 2 diabetes: A target for new therapies against cardiovascular diseases
Andreadi, A., Bellia, A., Daniele, N. D., Meloni, M., Lauro, R., Della‐Morte, D., & Lauro, D. (2021) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2021.11.010 · Cited by 136
Effects of thiamine and benfotiamine on intracellular glucose metabolism and relevance in the prevention of diabetic complications
Beltramo, E., Berrone, E., Tarallo, S., & Porta, M. (2008) · Acta Diabetologica · doi:10.1007/s00592-008-0042-y · Cited by 133
Exercise and Type 1 Diabetes (T1DM)
Galassetti, P. R., & Riddell, M. C. (2013) · Comprehensive physiology · doi:10.1002/cphy.c110040 · Cited by 143
C-Reactive Protein and Soluble Vascular Cell Adhesion Molecule-1 Are Associated With Elevated Urinary Albumin Excretion but Do Not Explain Its Link With Cardiovascular Risk
Jager, A., van Hinsbergh, V. W. M., Kostense, P. J., EMEIS, J. J., Nijpels, G., Dekker, J. M., Heine, R. J., Bouter, L. M., & Stehouwer, C. D. A. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000013786.80104.d4 · Cited by 128
Stress-Associated Endoplasmic Reticulum Protein 1 (Serp1)/Ribosome-Associated Membrane Protein 4 (Ramp4) Stabilizes Membrane Proteins during Stress and Facilitates Subsequent Glycosylation
Yamaguchi, A., Hori, O., Stern, D. M., Hartmann, E., Ogawa, S., & Tohyama, M. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.6.1195 · Cited by 126
Self-citation
Glucosamine-Induced Endoplasmic Reticulum Dysfunction Is Associated With Accelerated Atherosclerosis in a Hyperglycemic Mouse Model
Werstuck, G. H., Khan, M. I., Femia, G., Kim, A. J., Tedesco, V. C., Trigatti, B. L., & Shi, Y. (2006) · Diabetes · doi:10.2337/diabetes.55.01.06.db05-0633 · Cited by 124
Receptor for Advanced Glycation End Products Is Involved in Impaired Angiogenic Response in Diabetes
Shoji, T., Koyama, H., Morioka, T., Tanaka, S., Kizu, A., Motoyama, K., Mori, K., Fukumoto, S., Shioi, A., Shimogaito, N., et al. (2006) · Diabetes · doi:10.2337/db05-1375 · Cited by 124
High Serum Levels of Advanced Glycation End Products Predict Increased Coronary Heart Disease Mortality in Nondiabetic Women but not in Nondiabetic Men: A Population-Based 18-Year Follow-Up Study
Kilhovd, B. K., Juutilainen, A., Lehto, S., Rönnemaa, T., Torjesen, P. A., Birkeland, K. I., Berg, T. J., Hanssen, K. F., & Laakso, M. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000158380.44231.fe · Cited by 122
Manifestations of Cutaneous Diabetic Microangiopathy
Ngo, B., Hayes, K. D., DiMiao, D. J., Srinivasan, S. K., Huerter, C. J., & Rendell, M. (2005) · American Journal of Clinical Dermatology · doi:10.2165/00128071-200506040-00003 · Cited by 122
Cardiovascular disease in diabetes mellitus type 2: a potential role for novel cardiovascular risk factors
Hayden, J. M., & Reaven, P. D. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200010000-00010 · Cited by 121
A review of becaplermin gel in the treatment of diabetic neuropathic foot ulcers
Galiano (2008) · Biologics · doi:10.2147/btt.s1338 · Cited by 121
Glucose metabolism and coronary heart disease in patients with normal glucose tolerance
Sasso, F. C. (2004) · JAMA · doi:10.1001/jama.291.15.1857 · Cited by 117
The Relation of Markers of Inflammation and Endothelial Dysfunction to the Prevalence and Progression of Diabetic Retinopathy
Klein, R. (2009) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2009.172 · Cited by 118
Phagocyte dysfunction, tissue aging and degeneration
Li, W. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.05.006 · Cited by 116
Apoptosis in ischemic renal injury: Roles of GTP depletion and p53
Dagher, P. C. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.761_7.x · Cited by 118
Association Between Acute-Phase Reactants and Advanced Glycation End Products in Type 2 Diabetes
Tan, K. C. B., Chow, W.-S., Tam, S., Bucala, R., & Betteridge, J. D. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.223 · Cited by 117
Induction of HO-1 and redox signaling in endothelial cells by advanced glycation end products: A role for Nrf2 in vascular protection in diabetes
He, M., Siow, R. C. M., Sugden, D., Gao, L., Cheng, X., & Mann, G. E. (2010) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.12.008 · Cited by 116
Advanced glycation end products and their circulating receptors predict cardiovascular disease mortality in older community-dwelling women
Semba, R. D., Ferrucci, L., Sun, K., Beck, J., Dalal, M., Varadhan, R., Walston, J. D., Guralnik, J. M., & Fried, L. P. (2009) · Aging Clinical and Experimental Research · doi:10.1007/bf03325227 · Cited by 117
Reductive Metabolism of AGE Precursors: A Metabolic Route for Preventing AGE Accumulation in Cardiovascular Tissue
Baba, S. P., Barski, O. A., Ahmed, Y., O’Toole, T. E., Conklin, D. J., Bhatnagar, A., & Srivastava, S. (2009) · Diabetes · doi:10.2337/db09-0375 · Cited by 117
Bidirectional interactions between diabetes and Alzheimer's disease
Shinohara, M., & Sato, N. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.04.020 · Cited by 117
Neurodegeneration and Inflammation
DeLegge, M. H., & Smoke, A. (2008) · Nutrition in Clinical Practice · doi:10.1177/011542650802300135 · Cited by 114
A Phase IV, Randomized, Double-Blind, Placebo-Controlled Crossover Study of the Effects of Ustekinumab on Vascular Inflammation in Psoriasis (the VIP-U Trial)
Gelfand, J. M., Shin, D. B., Alavi, A. A., Torigian, D. A., Werner, T. J., Papadopoulos, M., Takeshita, J., Noe, M. H., Dey, A. K., Playford, M. P., et al. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.07.679 · Cited by 113
Enhanced Interaction of Advanced Glycation End Products With Their Cellular Receptor RAGE: Implications for the Pathogenesis of Accelerated Periodontal Disease in Diabetes
Lalla, E., Lamster, I. B., & Schmidt, A. M. (1998) · Annals of Periodontology · doi:10.1902/annals.1998.3.1.13 · Cited by 113
Self-citation
High-glucose-induced nuclear factor κB activation in vascular smooth muscle cells
Hattori, Y. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00425-3 · Cited by 112
Do Glucose and Lipids Exert Independent Effects on Atherosclerotic Lesion Initiation or Progression to Advanced Plaques?
Kanter, J. E., Johansson, F., LeBoeuf, R. C., & Bornfeldt, K. (2007) · Circulation Research · doi:10.1161/01.res.0000259589.34348.74 · Cited by 112
PPARγ Agonists Ameliorate Endothelial Cell Activation via Inhibition of Diacylglycerol–Protein Kinase C Signaling Pathway
Verrier, E., Wang, L., Wadham, C., Albanese, N., Hahn, C. N., Gamble, J. R., Chatterjee, K., Vadas, M. A., & Xia, P. (2004) · Circulation Research · doi:10.1161/01.res.0000130527.92537.06 · Cited by 111
Vitreous Levels of Vascular Cell Adhesion Molecule and Vascular Endothelial Growth Factor in Patients With Proliferative Diabetic Retinopathy
Hernández, C., Burgos, R., Cantón, A., García‐Arumí, J., Segura, R., & Simó, R. (2001) · Diabetes Care · doi:10.2337/diacare.24.3.516 · Cited by 111
Lowering of dietary advanced glycation endproducts (AGE) reduces neointimal formation after arterial injury in genetically hypercholesterolemic mice
Lin, R.-Y., Reis, E. D., Dore, A. T., Lu, M., Ghodsi, N., Fallon, J. T., Fisher, E. A., & Vlassara, H. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00008-4 · Cited by 109
Advanced Glycation End Products (AGEs) and Chronic Kidney Disease: Does the Modern Diet AGE the Kidney?
Fotheringham, A. K., Gallo, L. A., Borg, D. J., & Forbes, J. M. (2022) · Nutrients · doi:10.3390/nu14132675 · Cited by 116
Effect of α-lipoic acid on the progression of endothelial cell damage and albuminuria in patients with diabetes mellitus: an exploratory study
Morcos, M., Borcea, V., Isermann, B., Gehrke, S. G., Ehret, T., Henkels, M., Schiekofer, S., Hofmann, M. A., Amiral, J., Tritschler, H., et al. (2001) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(01)00223-6 · Cited by 109
RAGE, vascular tone and vascular disease
Farmer, D., & Kennedy, S. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.06.013 · Cited by 108
Characterization of the Advanced Glycation End-Product Receptor Complex in Human Vascular Endothelial Cells
Stitt, A. W., He, C., & Vlassara, H. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0291 · Cited by 107
High glucose accelerates MCP-1 production via p38 MAPK in vascular endothelial cells
Takaishi, H., Taniguchi, T., Takahashi, A., Ishikawa, Y., & Yokoyama, M. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00712-5 · Cited by 108
Mesothelial RAGE activation by AGEs enhances VEGF release and potentiates capillary tube formation
Boulanger, É., Grossin, N., Wautier, M.-P., Taamma, R., & Wautier, J. (2006) · Kidney International · doi:10.1038/sj.ki.5002016 · Cited by 107
AGE–RAGE Stress, Stressors, and Antistressors in Health and Disease
Mishra, M., & Prasad, K. (2017) · International Journal of Angiology · doi:10.1055/s-0037-1613678 · Cited by 111
Diabetes, prediabetes, and cardiovascular risk: Shifting the paradigm
DEEDWANIA, P. C., & Fonseca, V. A. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.05.018 · Cited by 107
Amelioration of oxidant stress by the defensin lysozyme
Liu, H., Zheng, F., Cao, Q., Ren, B., Zhu, L., Striker, G. E., & Vlassara, H. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00349.2005 · Cited by 106
Pulmonary receptor for advanced glycation end-products promotes asthma pathogenesis through IL-33 and accumulation of group 2 innate lymphoid cells
Oczypok, E. A., Milutinovic, P. S., Alcorn, J. F., Khare, A., Crum, L. T., Manni, M. L., Epperly, M. W., Pawluk, A. M., Ray, A., & Oury, T. D. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.03.011 · Cited by 105
Advanced Glycation Endproducts Stimulate Interleukin-6 Production by Human Bone-Derived Cells
Takagi, M., Kasayama, S., Yamamoto, T., Motomura, T., Hashimoto, K., Yamamoto, H., Sato, B., Okada, S., & Kishimoto, T. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.3.439 · Cited by 104
Uremic Toxins, Oxidative Stress, Atherosclerosis in Chronic Kidney Disease, and Kidney Transplantation
Wojtaszek, E., Ołdakowska‐Jedynak, U., Kwiatkowska, M., Głogowski, T., & Małyszko, J. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6651367 · Cited by 105
RAGE Expression in Human T Cells: A Link between Environmental Factors and Adaptive Immune Responses
Akirav, E. M., Preston‐Hurlburt, P., Garyu, J., Henegariu, O., Clynes, R., Schmidt, A. M., & Herold, K. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034698 · Cited by 105
Self-citation
Reduced cell replication and induction of apoptosis by advanced glycation end products in rat Schwann cells
Sekido, H., Suzuki, T., Jomori, T., Takeuchi, M., Yabe‐Nishimura, C., & Yagihashi, S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.05.159 · Cited by 105
Cyclooxygenase and 5‐lipoxygenase pathways in the vessel wall: Role in atherosclerosis
Vila, L. (2004) · Medicinal Research Reviews · doi:10.1002/med.10065 · Cited by 102
Advanced Glycation End Products-Induced Gene Expression of Scavenger Receptors in Cultured Human Monocyte-Derived Macrophages
Iwashima, Y., Eto, M., Hata, A., Kaku, K., Horiuchi, S., Ushikubi, F., & Sano, H. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3685 · Cited by 102
Upregulation of RAGE and its ligands in proliferative retinal disease
Pachydaki, S. I., Tari, S. R., Lee, S. E., Ma, W., Tseng, J., Sosunov, A. A., Cataldergirmen, G., Scarmeas, N., Caspersen, C. S., Chang, S., et al. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2005.09.022 · Cited by 101
Self-citation
Atherosclerosis and the vascular biology of aging
Crow, M. T. (1996) · Aging Clinical and Experimental Research · doi:10.1007/bf03339572 · Cited by 101
Receptor for Advanced Glycation End Products Expression on T Cells Contributes to Antigen-Specific Cellular Expansion In Vivo
Moser, B., Desai, D. D., Downie, M. P., Chen, Y., Yan, S. F., Herold, K. C., Schmidt, A. M., & Clynes, R. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.12.8051 · Cited by 100
Self-citation
Lipid glycation and protein glycation in diabetes and atherosclerosis
Miyazawa, T., Nakagawa, K., Shimasaki, S., & Nagai, R. (2010) · Amino Acids · doi:10.1007/s00726-010-0772-3 · Cited by 99
Monocytes promote natural killer cell interferon gamma production in response to the endogenous danger signal HMGB1
DeMarco, R., Fink, M. P., & Lotze, M. T. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.07.023 · Cited by 99
MMP‐Mediated Events in Diabetes
RYAN, M. E., RAMAMURTHY, N. S., Sorsa, T. A., & Golub, L. M. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07692.x · Cited by 99
Endothelial Dysfunction, Cellular Adhesion Molecules and the Metabolic Syndrome
Schram, M. T., & Stehouwer, C. D. A. (2005) · Hormone and Metabolic Research · doi:10.1055/s-2005-861363 · Cited by 98
Diabetes, leukoencephalopathy and rage
Toth, C. C., Schmidt, A. M., Tuor, U. I., Francis, G. J., Foniok, T., Brussee, V., Kaur, J., Yan, S. F., Martinez, J. A., Barber, P. A., et al. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.03.015 · Cited by 98
Self-citation
Structural Changes of the Heart During Severe Sepsis or Septic Shock
Smeding, L. S., Plötz, F. B., Groeneveld, A. B. J., & Kneyber, M. C. J. (2012) · Shock · doi:10.1097/shk.0b013e31824c3238 · Cited by 98
‘Lipoproteins, glycoxidation and diabetic angiopathy’
Jenkins, A. J., Best, J. D., Klein, R. L., & Lyons, T. J. (2004) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.491 · Cited by 96
The Physiological and Biochemical Effects of Diabetes on the Balance between Oxidative Stress and Antioxidant Defense SystemPreprint
Ahmed, R. G. (2005) · SSRN Electronic Journal · Cited by 95
Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes
Nakamura, K., Yamagishi, S., Adachi, H., Matsui, T., Kurita‐Nakamura, Y., Takeuchi, M., Inoue, H., & Imaizumi, T. (2007) · Microvascular Research · doi:10.1016/j.mvr.2007.09.004 · Cited by 96
Inflammation and advanced glycation end products in uremia: Simple coexistence, potentiation or causal relationship?
Schwedler, S. B., Schinzel, R., Vaith, P., & Wanner, C. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.59780032.x · Cited by 100
Cellular Signaling and Potential New Treatment Targets in Diabetic Retinopathy
Khan, Z. A., & Chakrabarti, S. (2007) · Journal of Diabetes Research · doi:10.1155/2007/31867 · Cited by 95
A murine model of accelerated periodontal disease in diabetes
Lalla, E., Lamster, I. B., Feit, M., Huang, L., & Schmidt, A. M. (1998) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.1998.tb02335.x · Cited by 95
Self-citation
Soluble leucocyte adhesion molecules in diabetic retinopathy stimulate retinal capillary endothelial cell migration
Olson, J. A., Whitelaw, C. M., McHardy, K. C., Pearson, D., & Forrester, J. V. (1997) · Diabetologia · doi:10.1007/s001250050802 · Cited by 95
Binding of receptor for advanced glycation end products (RAGE) ligands is not sufficient to induce inflammatory signals: lack of activity of endotoxin-free albumin-derived advanced glycation end products
Mone, M. D., Koehne, C., Rediske, J. J., Hughes, T. E., & Valencia, J. (2004) · Diabetologia · doi:10.1007/s00125-004-1392-9 · Cited by 94
Effects of OPB‐9195, anti‐glycation agent, on experimental diabetic neuropathy
Wada, R., Nishizawa, Y., Yagihashi, N., Takeuchi, M., Ishikawa, Y., YASUMURA, K., Nakano, M., & Yagihashi, S. (2001) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2001.00826.x · Cited by 93
Advanced glycation end products upregulate angiogenic and pro-inflammatory cytokine production in human monocyte/macrophages
Pertyńska−Marczewska, M., Kiriakidis, S., Wait, R., Beech, J. T., Feldmann, M., & Paleolog, E. M. (2004) · Cytokine · doi:10.1016/j.cyto.2004.06.006 · Cited by 94
Percutaneous coronary intervention in diabetic patients with non-ST-segment elevation acute coronary syndromes
Roffi, M. (2004) · European Heart Journal · doi:10.1016/j.ehj.2003.10.027 · Cited by 94
Epalrestat, an aldose reductase ihibitor, reduces the levels of Nepsilon-(carboxymethyl)lysine protein adducts and their precursors in erythrocytes from diabetic patients.
Hamada, Y., Nakamura, J., Naruse, K., Komori, T., Kato, K., Kasuya, Y., Nagai, R., Horiuchi, S., & Hotta, N. (2000) · Diabetes Care · doi:10.2337/diacare.23.10.1539 · Cited by 92
Divergent Pathways of Gene Expression Are Activated by the RAGE Ligands S100b and AGE-BSA
Valencia, J., Mone, M. D., Zhang, J., Weetall, M. L., Buxton, F. P., & Hughes, T. E. (2004) · Diabetes · doi:10.2337/diabetes.53.3.743 · Cited by 92
Self-citation
Effects of flavonoids on the expression of the pro‐inflammatory response in human monocytes induced by ligation of the receptor for AGEs
Huang, S., Wu, C., & Yen, G. (2006) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200600075 · Cited by 90
The SGLT2 Inhibitor Luseogliflozin Rapidly Normalizes Aortic mRNA Levels of Inflammation-Related but Not Lipid-Metabolism-Related Genes and Suppresses Atherosclerosis in Diabetic ApoE KO Mice
Nakatsu, Y., Kokubo, H., Batmunkh, B., Yoshizumi, M., Yamamotoya, T., Matsunaga, Y., Ueda, K., Inoue, Y., Inoue, M., Fujishiro, M., et al. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081704 · Cited by 90
Uremic Toxins and Vascular Dysfunction
Six, I., Flissi, N., Lenglet, G., Louvet, L., Kamel, S., Gallet, M., Massy, Z. A., & Liabeuf, S. (2020) · Toxins · doi:10.3390/toxins12060404 · Cited by 97
Effect of dietary prebiotic supplementation on advanced glycation, insulin resistance and inflammatory biomarkers in adults with pre-diabetes: a study protocol for a double-blind placebo-controlled randomised crossover clinical trial
Kellow, N. J., Coughlan, M. T., Savige, G. S., & Reid, C. M. (2014) · BMC Endocrine Disorders · doi:10.1186/1472-6823-14-55 · Cited by 93
A review of recent advances and current hypotheses on the pathogenesis of acute laminitis
Katz, L. M., & Bailey, S. R. (2012) · Equine Veterinary Journal · doi:10.1111/j.2042-3306.2012.00664.x · Cited by 88
Autoimmune response to advanced glycosylation end-products of human LDL
Virella, G., Thorpe, S. R., Alderson, N. L., Stephan, E. M., Atchley, D. H., Wagner, F., & Lopes-Virella, M. F. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200370-jlr200 · Cited by 88
The influence of improved glycaemic control with insulin and sulphonylureas on acute phase and endothelial markers in Type II Diabetic subjects
Yudkin, J. S., Panahloo, A., Stehouwer, C. D. A., EMEIS, J. J., Bulmer, K., Mohamed‐Ali, V., & Denver, A. E. (2000) · Diabetologia · doi:10.1007/s001250051500 · Cited by 88
Activation of NFκB and MnSOD gene expression by free radical scavengers in human microvascular endothelial cells
Murley, J. S., Kataoka, Y., Hallahan, D. E., Roberts, J. C., & Grdina, D. J. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00554-8 · Cited by 86
Benfotiamine accelerates the healing of ischaemic diabetic limbs in mice through protein kinase B/Akt-mediated potentiation of angiogenesis and inhibition of apoptosis
Gadau, S. D., Emanueli, C., Linthout, S. V., Graiani, G., Todaro, M., Meloni, M., Campesi, I., Invernici, G., Spillmann, F., Ward, K., et al. (2006) · Diabetologia · doi:10.1007/s00125-005-0103-5 · Cited by 85
The receptor for advanced glycation end-products has a central role in mediating the effects of advanced glycation end-products on the development of vascular disease in diabetes mellitus
Hori, O., Yan, S. D., Ogawa, S., Kuwabara, K., Matsumoto, M., Stern, D., & Schmidt, A. M. (1996) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/11.supp5.13 · Cited by 84
Self-citation
Accumulation of Advanced Glycation End-Products in the Body and Dietary Habits
Zawada, A. E., Machowiak, A., Rychter, A. M., Ratajczak, A. E., Szymczak‐Tomczak, A., Dobrowolska, A., & Krela‐Kaźmierczak, I. (2022) · Nutrients · doi:10.3390/nu14193982 · Cited by 87
Atherogenesis and Advanced Glycation: Promotion, Progression, and Preventiona
Stitt, A. W., Bucala, R., & Vlassara, H. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb51994.x · Cited by 83
Sp1-binding Elements in the Promoter of RAGE Are Essential for Amphoterin-mediated Gene Expression in Cultured Neuroblastoma Cells
Li, J., Qu, X., & Schmidt, A. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.47.30870 · Cited by 82
Self-citation
Self-assembled elastin-like polypeptide fusion protein coacervates as competitive inhibitors of advanced glycation end-products enhance diabetic wound healing
Kang, H. J., Kumar, S., D'Elia, A., Dash, B. C., Nanda, V., Hsia, H. C., Yarmush, M. L., & Francois Berthiaume, B. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.03.032 · Cited by 84
Regulation of advanced glycation end product (AGE)-receptor (RAGE) system by PPAR-gamma agonists and its implication in cardiovascular disease
Yamagishi, S., Nakamura, K., & Matsui, T. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.01.006 · Cited by 81
Heme oxygenase (HO)-1 induction prevents Endoplasmic Reticulum stress-mediated endothelial cell death and impaired angiogenic capacity
Maamoun, H., Zachariah, M., McVey, J. H., Green, F. R., & Agouni, A. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.12.009 · Cited by 81
Glyco-oxidation and cardiovascular complications in type 2 diabetes: a clinical update
Piarulli, F., Sartore, G., & Lapolla, A. (2012) · Acta Diabetologica · doi:10.1007/s00592-012-0412-3 · Cited by 80
Pathophysiological Mechanisms of Diabetes-Induced Macrovascular and Microvascular Complications: The Role of Oxidative Stress
Roy, B. (2025) · Medical Sciences · doi:10.3390/medsci13030087 · Cited by 103
Receptor for Advanced Glycation End Products (RAGE) and Implications for the Pathophysiology of Heart Failure
Ramasamy, R., & Schmidt, A. M. (2012) · Current Heart Failure Reports · doi:10.1007/s11897-012-0089-5 · Cited by 79
Self-citation
Accumulation of modified proteins and aggregate formation in aging
Nowotny, K., Jung, T., Grune, T., & Höhn, A. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.05.016 · Cited by 84
Empagliflozin restores chronic kidney disease–induced impairment of endothelial regulation of cardiomyocyte relaxation and contraction
Juni, R. P., Al‐Shama, R., Kuster, D. W. D., van der Velden, J., Hamer, H. M., Vervloet, M. G., Eringa, E. C., Koolwijk, P., & van Hinsbergh, V. W. M. (2020) · Kidney International · doi:10.1016/j.kint.2020.12.013 · Cited by 79
Circulating soluble vascular cell adhesion molecule 1: Relationships with residual renal function, cardiac hypertrophy, and outcome of peritoneal dialysis patients
Wang, A. Y.-M., Lam, C. W.-K., Wang, M., Woo, J., Chan, I. H.-S., Lui, S., Sanderson, J. E., & Li, P. K. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.12.012 · Cited by 79
Receptor for advanced glycation end products--soluble form and gene polymorphisms in chronic haemodialysis patients
Kalousová, M., Jáchymová, M., Mestek, O., Hodkova, M., Kazderová, M., Tesař, V., & Zima, T. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm050 · Cited by 79
Elevated circulating adhesion molecules in NIDDM — potential mediators in diabetic macroangiopathy
Fasching, P., Waldhäusl, W., & Wagner, O. F. (1996) · Diabetologia · doi:10.1007/bf02658518 · Cited by 79

Authors: Schmidt, A. M., Hori, O., Chen, J. X., Li, J. F., Crandall, J., Zhang, J., Cao, R., Yan, S. D., Brett, J., & Stern, D.
Affiliations: Columbia University Irving Medical Center (US)
Columbia University (US)
ORCID: Hori, O
Crandall, J
Zhang, J
Cao, R
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 1995-09-01
Volume: 96
Issue: 3
Pages: 1395-1403
ISSN: 0021-9738 (ISSN-L)
DOI: 10.1172/jci118175
PMC: PMC185762
OpenAlex: W2138928713
Cited by: 896
References: 43
Citations by year: 2026: 5 · 2025: 11 · 2024: 15 · 2023: 16 · 2022: 13 · 2021: 21 · 2020: 16 · 2019: 23 · 2018: 16 · 2017: 26 · 2016: 17 · 2015: 34 · 2014: 32 · 2013: 35 · 2012: 36
FWCI: 17.32
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Clinical Investigation (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
KU ScholarWorks (University of Kansas) (submittedVersion, other-oa)
Funders: American Heart Association
National Institutes of Health (5r01hl042833-10, 5p50hl021006-17)
U.S. Public Health Service
National Institute on Aging (AG00602)
National Heart, Lung, and Blood Institute (HL-42833, HL 21006)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
Keywords: advanced glycation end products, receptor for advanced glycation end products, VCAM-1, endothelial cells, diabetes mellitus, diabetic vascular disease, oxidative stress, NF-kB, soluble RAGE, N-acetylcysteine, monocyte adhesion, atherosclerosis, soluble VCAM-1
MeSH terms: Receptor for Advanced Glycation End Products, Animals, Base Sequence, Cell Adhesion, Cell Line, Cell Nucleus, Cells, Cultured, Diabetic Angiopathies, Endothelium, Vascular, Enzyme-Linked Immunosorbent Assay, Humans, Male, Models, Biological, Molecular Sequence Data, Receptors, Immunologic, Transcription, Genetic, Umbilical Veins, Cell Adhesion Molecules, Gene Expression, Polymerase Chain Reaction, Glycation End Products, Advanced, DNA Primers, Oxidative Stress, Vascular Cell Adhesion Molecule-1, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks